Gain Therapeutics Inc
NASDAQ:GANX
Income Statement
Earnings Waterfall
Gain Therapeutics Inc
Revenue
|
55.2k
USD
|
Operating Expenses
|
-22.3m
USD
|
Operating Income
|
-22.3m
USD
|
Other Expenses
|
-14.4k
USD
|
Net Income
|
-22.3m
USD
|
Income Statement
Gain Therapeutics Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
0
N/A
|
0
+30%
|
0
+23%
|
0
+31%
|
0
+5%
|
0
-14%
|
0
-26%
|
0
+14%
|
0
-63%
|
0
N/A
|
0
-8%
|
|
Operating Income | ||||||||||||
Operating Expenses |
(6)
|
(11)
|
(14)
|
(15)
|
(17)
|
(17)
|
(18)
|
(20)
|
(22)
|
(22)
|
(22)
|
|
Selling, General & Administrative |
(3)
|
(5)
|
(7)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
|
Research & Development |
(3)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(10)
|
(11)
|
(11)
|
(11)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
Operating Income |
(6)
N/A
|
(11)
-78%
|
(14)
-30%
|
(15)
-6%
|
(16)
-11%
|
(16)
-1%
|
(18)
-8%
|
(20)
-11%
|
(22)
-13%
|
(22)
-1%
|
(22)
+1%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(6)
N/A
|
(11)
-78%
|
(14)
-30%
|
(15)
-6%
|
(16)
-10%
|
(16)
+1%
|
(18)
-8%
|
(19)
-11%
|
(22)
-13%
|
(22)
-1%
|
(22)
-1%
|
|
Net Income | ||||||||||||
Tax Provision |
0
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(6)
|
(11)
|
(14)
|
(15)
|
(16)
|
(16)
|
(18)
|
(19)
|
(22)
|
(22)
|
(22)
|
|
Net Income (Common) |
(6)
N/A
|
(11)
-78%
|
(14)
-30%
|
(15)
-6%
|
(16)
-10%
|
(16)
+1%
|
(18)
-9%
|
(19)
-11%
|
(22)
-13%
|
(22)
-1%
|
(22)
0%
|
|
EPS (Diluted) |
-0.51
N/A
|
-0.9
-76%
|
-1.37
-52%
|
-1.24
+9%
|
-1.37
-10%
|
-1.36
+1%
|
-1.48
-9%
|
-1.63
-10%
|
-1.78
-9%
|
-1.74
+2%
|
-1.71
+2%
|